Anybody know what happened to Entomed's insect-
based libraries? "Entomotheque"
I see there was an auction in June, and you can
only get to the company website by looking at
google cache>text only.
Actellion had an antiviral deal with Entomed,
and I see that this fella sat on both boards,
so I'm tempted to fire off an email out of curiosity.
Maybe I'll have Renee check my grammar and convert it
to french so it doesn't look like it came from
an idiot stock trader guy <g>.
prnewswire.co.uk
Joel Besse joined Atlas Venture in 1995. After serving as an auditor at Arthur Andersen and at Credit Lyonnais in Paris, he began his career in venture capital in 1991 with SED Ventures, a French venture firm specializing in international life sciences investments. Mr. Besse holds a Master of Science degree from the University of Toulouse and graduated from Ecole Nationale Superieure de I'Aeronautique et de l'Espace. He serves on the boards of Actelion, B2Build, EntoMed, EuropAgri, IDM, Modex, Novuspharma and Saphir Medical.
atlasventure.com
presently sits on these boards:
Arrow Therapeutics, Newron Pharmaceuticals, Prestwick Pharmaceuticals, Sporever, U3 Pharma, Xytis Pharmaceuticals |
